SHORT MINI FUTURE - PFIZER INC | Market Closed - Bid/Ask 16:20:00 17/06/2024 BST | After market 16:15:01 | |||
| 2.39 CHF | +0.84% |
|
2.365 | -1.05% |
| Current month | +3.46% | ||
| 1 month | +3.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 17/06/24 | 2.39 | +0.84% |
| 13/06/24 | 2.37 | +1.28% |
| 12/06/24 | 2.34 | +0.43% |
| 10/06/24 | 2.33 | +4.02% |
Delayed Quote Swiss Exchange
Last update June 17, 2024 at 04:20 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | Bank Julius Bär |
| LPFAJB | |
| ISIN | CH1242489479 |
| Date issued | 12/01/2023 |
| Strike | 53.73 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | - CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 2.65 CHF |
|---|---|
| Lowest since issue | 0.68 CHF |
| Spread | 0.01 CHF |
| Spread % | 0.42% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
26.98
USD
Average target price
31.92
USD
Spread / Average Target
+18.29%
- Stock Market
- Certificates
- LPFAJB Certificat